enGene Therapeutics Inc. (ENGN) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $1.49M | +60.5% |
| 2024 | $925.0K | +190.9% |
| 2023 | $318.0K | +107.8% |
| 2022 | $153.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $1.49M | +60.5% |
| 2024 | $925.0K | +190.9% |
| 2023 | $318.0K | +107.8% |
| 2022 | $153.0K | — |